Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (2): 189-197.doi: 10.12092/j.issn.1009-2501.2023.02.010

Previous Articles     Next Articles

State of clinical application of meloxicam

LI Xinyu1,2, HUANG Xin1,2,3   

  1. 1Institute of Pharmaceutical Research, New Drug Screening Center, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; 2Jiangsu Center for Pharmacodynamics Research and Evaluation, Nanjing 210009, Jiangsu, China; 3Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, Jiangsu, China
  • Received:2022-10-08 Revised:2022-12-23 Online:2023-02-26 Published:2023-03-10

Abstract:

Meloxicam is a long-acting non-steroidal anti-inflammatory drug, which is mainly used in the treatment of chronic osteoarthritis and postoperative analgesia. Recent studies have found that the drug has great therapeutic potential in anti-tumor, improving cognitive impairment in Alzheimer's disease, mobilizing hematopoietic stem cells and so on. This paper reviewed the pharmacological mechanism of meloxicam, the adverse reactions in gastrointestinal tract, kidney, liver and cardiovascular aspects, summarized various forms of clinical application from the perspective of preparation, and summarized the current clinical treatment strategy of combining with Western medicine and Chinese medicine respectively.

Key words: meloxicam, adverse reactions, pharmacological mechanism, drug combination

CLC Number: